Spanish pharmaceutical company Rowe investigates Modena vaccine production accident or is related to Japan’s suspension of batch use-teller report

CCTV News Client News According to the Spanish “Nation” report, on August 26 local time, Japanese officials issued a statement saying that about 1.63 million doses of Modena’s new crown vaccine will be suspended due to impurities in the vaccine. The Spanish pharmaceutical company Rovi subsequently responded Investigation into possible production accidents of three batches of Modena vaccines was launched.

Rowe is a strategic partner of Modena in Spain, and can produce 600 million doses of Modena’s new crown vaccine every year. Modena believes that some doses of vaccines suspended in Japan may originate from a production line accident at a Spanish manufacturing plant, and Rowe is investigating possible vaccine batches.

At present, Rowe has not responded positively to this incident, nor has it stopped its production of the new crown vaccine in Modena, Spain. (Headquarters reporter Li Yaoyang)